Use of recombinant myelin protein for treating T-cell-mediated autoimmune diseases of the peripheral nervous system
US6319892A · kind A · utility
1Cited by
0References
6Claims
0Family size
Inventors
Key dates
| Filing date | Mar 15, 1999 |
| Grant date | Nov 20, 2001 |
| Priority date | — |
| Expiry date | Mar 15, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/1738
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the use of recombinant myelin protein for treating T cell-mediated autoimmune diseases of the peripheral nervous system.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.